Catalyst Wire Dossier Catalyst Wire Dossier

NeoVas Bioresorbable Coronary Scaffold

· Lepu Medical Technology (Beijing) Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NeoVas Bioresorbable Coronary Scaffold, covering 2016-03-14 to 2017-03-09. Get the full timeline:

Most recent: Clinical Trial Update: NeoVas Bioresorbable Coronary Scaffold Registry Study [NA]

See pricing